Paul Tudor Jones Insulet Corp Call Options Transaction History

Tudor Investment Corp Et Al

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 15, 2024	BUY	$163.6 - $209.11 $507,160 - $648,241	3,100 Added 310.0%	4,100 $702,000
Q4 2023 Feb 14, 2024	SELL	$127.77 - $221.42 $4.1 Million - $7.11 Million	-32,100 Reduced 96.98%	1,000 $216,000
Q3 2023 Nov 15, 2023	BUY	$154.67 - $290.89 $5.12 Million - $9.63 Million	33,100 New	33,100 $5.28 Million
Q4 2022 Feb 14, 2023	BUY	$212.22 - $313.46 $381,996 - $564,228	1,800 New	1,800 $530,000

685

62.7M

640K

881K

Ticker PODD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 69,403,600
Market Cap $18.1B
Description
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.